Xin Lang Cai Jing·2025-10-10 09:37Core Viewpoint - The trademark dispute over "Wanglaoji" has intensified, with both JDB Group and Guangzhou Wanglaoji Health Industry Co., Ltd. claiming ownership of the overseas trademark rights [1] Group 1: JDB Group's Position - On October 10, JDB Group announced it holds the overseas trademark rights for Wanglaoji, claiming to have acquired the rights from Wanglaoji's descendants in the 1990s [1] - JDB Group asserts that it legally obtained the overseas trademark ownership in the 2000s and has registered the Wanglaoji trademark in 60 major countries and regions worldwide [1] - The company plans to take legal action to protect its rights against what it describes as false claims regarding the overseas Wanglaoji brand rights [1] Group 2: Guangzhou Wanglaoji Health Industry Co., Ltd.'s Position - On September 30, Guangzhou Wanglaoji Health Industry Co., Ltd. accused JDB Group of malicious trademark registration, asserting that the Wanglaoji trademark is owned by Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. [1] - The company claims to have registered the "Wanglaoji" and "WALOVI" series trademarks in over 100 countries and regions globally [1] - It alleges that JDB Group has interfered with its normal overseas business expansion through malicious registrations by offshore affiliates [1]